144 related articles for article (PubMed ID: 15769460)
21. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
Paulis L; Matuskova J; Adamcova M; Pelouch V; Simko J; Krajcirovicova K; Potacova A; Hulin I; Janega P; Pechanova O; Simko F
Acta Physiol (Oxf); 2008 Sep; 194(1):45-55. PubMed ID: 18419778
[TBL] [Abstract][Full Text] [Related]
22. Chronic (-)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats.
Gómez-Guzmán M; Jiménez R; Sánchez M; Romero M; O'Valle F; Lopez-Sepulveda R; Quintela AM; Galindo P; Zarzuelo MJ; Bailón E; Delpón E; Perez-Vizcaino F; Duarte J
Br J Nutr; 2011 Nov; 106(9):1337-48. PubMed ID: 21910946
[TBL] [Abstract][Full Text] [Related]
23. Signal transduction involving Ras-GTPase contributes to development of hypertension and end-organ damage in spontaneously hypertensive rats-treated with L-NAME.
Benter IF; Francis I; Khan I; Cojocel C; Juggi JS; Yousif MH; Canatan H; Alshawaf EH; Akhtar S
Pharmacol Res; 2005 Nov; 52(5):401-12. PubMed ID: 16027001
[TBL] [Abstract][Full Text] [Related]
24. Myocardial vasoactive intestinal peptide and fibrosis induced by nitric oxide synthase inhibition in the rat.
Ye VZ; Hodge G; Yong JL; Duggan KA
Acta Physiol Scand; 2003 Dec; 179(4):353-60. PubMed ID: 14656372
[TBL] [Abstract][Full Text] [Related]
25. Renoprotective effects of melatonin in young spontaneously hypertensive rats with L-NAME.
Cheng MC; Wu TH; Huang LT; Tain YL
Pediatr Neonatol; 2014 Jun; 55(3):189-95. PubMed ID: 24268813
[TBL] [Abstract][Full Text] [Related]
26. Enhanced expression of serum and glucocorticoid-inducible kinase-1 in kidneys of L-NAME-treated rats.
Feng Y; Wang Y; Xiong J; Liu Z; Yard B; Lang F
Kidney Blood Press Res; 2006; 29(2):94-9. PubMed ID: 16710099
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular effects of chronic inhibition of nitric oxide synthesis and dietary salt in spontaneously hypertensive rats.
Vaskonen T; Mervaala E; Krogerus L; Teräväinen TL; Laakso J; Karppanen H; Vapaatalo H
Hypertens Res; 1997 Sep; 20(3):183-92. PubMed ID: 9328799
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME.
Benter IF; Yousif MH; Anim JT; Cojocel C; Diz DI
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H684-91. PubMed ID: 16403946
[TBL] [Abstract][Full Text] [Related]
29. Hypertensive end-organ damage and premature mortality are p38 mitogen-activated protein kinase-dependent in a rat model of cardiac hypertrophy and dysfunction.
Behr TM; Nerurkar SS; Nelson AH; Coatney RW; Woods TN; Sulpizio A; Chandra S; Brooks DP; Kumar S; Lee JC; Ohlstein EH; Angermann CE; Adams JL; Sisko J; Sackner-Bernstein JD; Willette RN
Circulation; 2001 Sep; 104(11):1292-8. PubMed ID: 11551882
[TBL] [Abstract][Full Text] [Related]
30. Ferulic acid improves cardiovascular and kidney structure and function in hypertensive rats.
Alam MA; Sernia C; Brown L
J Cardiovasc Pharmacol; 2013 Mar; 61(3):240-9. PubMed ID: 23188120
[TBL] [Abstract][Full Text] [Related]
31. Female SHR have greater blood pressure sensitivity and renal T cell infiltration following chronic NOS inhibition than males.
Brinson KN; Elmarakby AA; Tipton AJ; Crislip GR; Yamamoto T; Baban B; Sullivan JC
Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(7):R701-10. PubMed ID: 23883679
[TBL] [Abstract][Full Text] [Related]
32. Endothelin-1 gene expression in blood vessels and kidney of spontaneously hypertensive rats (SHR), L-NAME-treated SHR, and renovascular hypertensive rats.
Deng LY; Schiffrin EL
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S380-3. PubMed ID: 9595489
[TBL] [Abstract][Full Text] [Related]
33. L-NAME-treatment alters ectonucleotidase activities in kidney membranes of rats.
Fürstenau CR; Ramos DB; Vuaden FC; Casali EA; Monteiro Pde S; Trentin Dda S; Gossenheimer AN; Bogo MR; Bonan CD; Barreto-Chaves ML; Sarkis JJ; Wofchuk ST
Life Sci; 2010 Aug; 87(9-10):325-32. PubMed ID: 20655932
[TBL] [Abstract][Full Text] [Related]
34. Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro-L-arginine-methyl ester hypertensive rats.
Paulis L; Pechanova O; Zicha J; Krajcirovicova K; Barta A; Pelouch V; Adamcova M; Simko F
J Hypertens Suppl; 2009 Aug; 27(6):S11-6. PubMed ID: 19633445
[TBL] [Abstract][Full Text] [Related]
35. Kidney adaptation in nitric oxide-deficient Wistar and spontaneously hypertensive rats.
Pereira LM; Almeida JR; Mandarim-de-Lacerda CA
Life Sci; 2004 Jan; 74(11):1375-86. PubMed ID: 14706568
[TBL] [Abstract][Full Text] [Related]
36. Nitric oxide and preglomerular vascular lesions in lyon spontaneously hypertensive rats.
Casellas D; Bouriquet N; Artuso A
Acta Physiol Scand; 2000 Jan; 168(1):133-8. PubMed ID: 10691791
[TBL] [Abstract][Full Text] [Related]
37. Beneficial effect of enalapril in spontaneously hypertensive rats cardiac remodeling with nitric oxide synthesis blockade.
de Andrade Zorzi RL; Meirelles Pereira LM; Mandarim-de-Lacerda CA
J Cell Mol Med; 2002; 6(4):599-608. PubMed ID: 12611644
[TBL] [Abstract][Full Text] [Related]
38. Endothelin and gelatinases in renal changes following blockade of nitric oxide synthase in hypertensive rats.
Yang YL; Liu DD; Hsieh NK; Chen HI
Chin J Physiol; 2008 Jun; 51(3):186-95. PubMed ID: 18935914
[TBL] [Abstract][Full Text] [Related]
39. [Hypertensive organ injuries in spontaneously hypertensive rats given N(G)-nitro-L-arginine methyl ester].
Ishimitsu T; Ono H; Matsuoka H
Nihon Rinsho; 2006 Jul; 64 Suppl 5():278-83. PubMed ID: 16895196
[No Abstract] [Full Text] [Related]
40. Hydrochlorothiazide exacerbates nitric oxide-blockade nephrosclerosis with glomerular hypertension in spontaneously hypertensive rats.
Ono Y; Ono H; Frohlich ED
J Hypertens; 1996 Jul; 14(7):823-8. PubMed ID: 8818920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
